𝔖 Bobbio Scriptorium

✦ LIBER ✦

UK's proposed research cuts show government's lack of understanding

✍ Scribed by The Lancet Oncology

Book ID: 117785485
Publisher: The Lancet
Year: 2010
Tongue: English
Weight: 77 KB
Volume: 11
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(10)70231-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

UK research grants suffer from SERC's la

UK research grants suffer from SERC's lack of money

✍ McGourty, Christine 📂 Article 📅 1989 🏛 Nature Publishing Group 🌐 English ⚖ 128 KB

Proposed methods for reviewing the outco

Proposed methods for reviewing the outcomes of health research: the impact of funding by the UK's 'Arthritis Research Campaign'

✍ Stephen R Hanney; Jonathan Grant; Steven Wooding; Martin J Buxton 📂 Article 📅 2004 🏛 BioMed Central 🌐 English ⚖ 287 KB

‘Impact’ in the proposals for the UK's R

‘Impact’ in the proposals for the UK's Research Excellence Framework: Shifting the boundaries of academic autonomy

✍ Simon Smith; Vicky Ward; Allan House 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 419 KB

Proposal for Establishment by the U.S. G

Proposal for Establishment by the U.S. Government of a Program for Regular Long-Range and World-Wide Training for International Understanding

✍ Omer C. Stewart 📂 Article 📅 1961 🏛 Wiley (Blackwell Publishing) ⚖ 156 KB

Can multiparametric magnetic resonance i

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St Peter׳s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.

✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 415 KB